vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $78.2M, roughly 1.1× Sezzle Inc.). Sezzle Inc. runs the higher net margin — 54.6% vs -38.1%, a 92.6% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (61.6% vs 20.2%). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (76.0% CAGR vs 24.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.

PRCT vs SEZL — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$78.2M
SEZL
Growing faster (revenue YoY)
SEZL
SEZL
+41.4% gap
SEZL
61.6%
20.2%
PRCT
Higher net margin
SEZL
SEZL
92.6% more per $
SEZL
54.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
SEZL
SEZL
Annualised
SEZL
76.0%
24.8%
PRCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SEZL
SEZL
Revenue
$83.1M
$78.2M
Net Profit
$-31.6M
$42.7M
Gross Margin
64.9%
Operating Margin
-4.1%
70.6%
Net Margin
-38.1%
54.6%
Revenue YoY
20.2%
61.6%
Net Profit YoY
-27.9%
68.3%
EPS (diluted)
$-0.56
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SEZL
SEZL
Q1 26
$83.1M
Q4 25
$76.4M
$78.2M
Q3 25
$83.3M
$57.5M
Q2 25
$79.2M
$52.0M
Q1 25
$69.2M
$48.2M
Q4 24
$68.2M
$48.4M
Q3 24
$58.4M
$35.6M
Q2 24
$53.4M
$30.2M
Net Profit
PRCT
PRCT
SEZL
SEZL
Q1 26
$-31.6M
Q4 25
$-29.8M
$42.7M
Q3 25
$-21.4M
$26.7M
Q2 25
$-19.6M
$27.6M
Q1 25
$-24.7M
$36.2M
Q4 24
$-18.9M
$25.4M
Q3 24
$-21.0M
$15.4M
Q2 24
$-25.6M
$29.7M
Gross Margin
PRCT
PRCT
SEZL
SEZL
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
SEZL
SEZL
Q1 26
-4.1%
Q4 25
-40.6%
70.6%
Q3 25
-27.8%
61.9%
Q2 25
-28.0%
69.4%
Q1 25
-39.7%
Q4 24
-28.9%
63.8%
Q3 24
-38.4%
58.6%
Q2 24
-50.3%
55.3%
Net Margin
PRCT
PRCT
SEZL
SEZL
Q1 26
-38.1%
Q4 25
-39.1%
54.6%
Q3 25
-25.7%
46.4%
Q2 25
-24.7%
53.1%
Q1 25
-35.8%
75.1%
Q4 24
-27.6%
52.4%
Q3 24
-35.9%
43.4%
Q2 24
-48.0%
98.4%
EPS (diluted)
PRCT
PRCT
SEZL
SEZL
Q1 26
$-0.56
Q4 25
$-0.54
$1.19
Q3 25
$-0.38
$0.75
Q2 25
$-0.35
$0.78
Q1 25
$-0.45
$1.00
Q4 24
$-0.34
$0.71
Q3 24
$-0.40
$0.44
Q2 24
$-0.50
$0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SEZL
SEZL
Cash + ST InvestmentsLiquidity on hand
$245.6M
$64.1M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$169.8M
Total Assets
$487.1M
$400.2M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SEZL
SEZL
Q1 26
$245.6M
Q4 25
$286.5M
$64.1M
Q3 25
$294.3M
$104.1M
Q2 25
$302.7M
$88.9M
Q1 25
$316.2M
$88.9M
Q4 24
$333.7M
$73.2M
Q3 24
$196.8M
$80.1M
Q2 24
$214.1M
$58.0M
Total Debt
PRCT
PRCT
SEZL
SEZL
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SEZL
SEZL
Q1 26
$347.7M
Q4 25
$365.9M
$169.8M
Q3 25
$380.3M
$155.3M
Q2 25
$385.8M
$130.4M
Q1 25
$389.2M
$125.8M
Q4 24
$402.2M
$87.8M
Q3 24
$241.2M
$61.1M
Q2 24
$251.8M
$50.3M
Total Assets
PRCT
PRCT
SEZL
SEZL
Q1 26
$487.1M
Q4 25
$508.1M
$400.2M
Q3 25
$511.5M
$367.0M
Q2 25
$513.1M
$350.6M
Q1 25
$519.4M
$298.1M
Q4 24
$534.0M
$298.4M
Q3 24
$374.1M
$252.9M
Q2 24
$374.4M
$212.1M
Debt / Equity
PRCT
PRCT
SEZL
SEZL
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SEZL
SEZL
Operating Cash FlowLast quarter
$70.6M
Free Cash FlowOCF − Capex
$70.6M
FCF MarginFCF / Revenue
90.2%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$209.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SEZL
SEZL
Q1 26
Q4 25
$-10.3M
$70.6M
Q3 25
$-6.6M
$63.7M
Q2 25
$-15.0M
$23.1M
Q1 25
$-17.0M
$52.5M
Q4 24
$-32.4M
$57.4M
Q3 24
$-18.8M
$35.1M
Q2 24
$-15.7M
$22.2M
Free Cash Flow
PRCT
PRCT
SEZL
SEZL
Q1 26
Q4 25
$-12.2M
$70.6M
Q3 25
$-9.5M
$63.6M
Q2 25
$-17.8M
$22.7M
Q1 25
$-18.8M
$52.5M
Q4 24
$-33.6M
$57.4M
Q3 24
$-19.0M
$35.1M
Q2 24
$-16.8M
$22.2M
FCF Margin
PRCT
PRCT
SEZL
SEZL
Q1 26
Q4 25
-15.9%
90.2%
Q3 25
-11.4%
110.6%
Q2 25
-22.5%
43.6%
Q1 25
-27.2%
108.9%
Q4 24
-49.2%
118.5%
Q3 24
-32.6%
98.6%
Q2 24
-31.4%
73.4%
Capex Intensity
PRCT
PRCT
SEZL
SEZL
Q1 26
Q4 25
2.4%
0.1%
Q3 25
3.4%
0.3%
Q2 25
3.5%
0.8%
Q1 25
2.7%
0.1%
Q4 24
1.7%
0.1%
Q3 24
0.4%
0.0%
Q2 24
2.0%
0.1%
Cash Conversion
PRCT
PRCT
SEZL
SEZL
Q1 26
Q4 25
1.65×
Q3 25
2.39×
Q2 25
0.84×
Q1 25
1.45×
Q4 24
2.26×
Q3 24
2.27×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SEZL
SEZL

Merchant And Partner Income$28.9M37%
Transaction Income$25.9M33%
Income From Other Services Late Payment Fees$20.5M26%
Other$2.9M4%

Related Comparisons